Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17660482 | 1.00 | ACE (0.75) | ACELMNAF2 | |
| SCHEMBL27890166 | 1.00 | ACE (0.75) | ACELMNAF2 | |
| SCHEMBL27890164 | 0.89 | ACE (0.73) | ACELMNAF2 | |
| SCHEMBL27890165 | 0.89 | ACE (0.73) | ACELMNAF2 | |
| Lisinopril Anhydrous SCHEMBL24062681 | 0.86 | ACE (1.00) | ACELMNA | |
| Lisinopril Anhydrous SCHEMBL7268245 | 0.86 | ACE (1.00) | ACELMNA | |
| Lisinopril Anhydrous SCHEMBL15680 | 0.86 | ACE (1.00) | ACELMNA | |
| Lisinopril Anhydrous SCHEMBL649165 | 0.86 | ACE (1.00) | ACELMNA | |
| Lisinopril Anhydrous SCHEMBL18712916 | 0.86 | ACE (1.00) | ACELMNA | |
| Lisinopril Anhydrous SCHEMBL156900 | 0.86 | ACE (1.00) | ACELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102924567-A | Peptide compound and preparation method and use of peptide compound | SHANGHAI INST PHARM INDUSTRY | 2013-02-13 | — | — | CN | claimed |
| CN-102924567-B | Peptide compound and preparation method and use of peptide compound | SHANGHAI INST PHARM INDUSTRY | 2014-06-04 | — | — | CN | disclosed |
| CN-102924567-A | Peptide compound and preparation method and use of peptide compound | SHANGHAI INST PHARM INDUSTRY | 2013-02-13 | — | — | CN | disclosed |